A

AFC-HD AMS Life Science Co Ltd
TSE:2927

Watchlist Manager
AFC-HD AMS Life Science Co Ltd
TSE:2927
Watchlist
Price: 883 JPY -0.11%
Market Cap: 12.4B JPY

Wall Street
Price Targets

Price Targets Summary
AFC-HD AMS Life Science Co Ltd

There are no price targets for AFC-HD AMS Life Science Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
AFC-HD AMS Life Science Co Ltd Competitors:
Price Targets
2931
Euglena Co Ltd
66% Upside
HNST
Honest Company Inc
48% Upside
600315
Shanghai Jahwa United Co Ltd
10% Upside
4928
Noevir Holdings Co Ltd
7% Upside
JWEL
Jamieson Wellness Inc
30% Upside
BEI
Beiersdorf AG
26% Upside
2367
Giant Biogene Holding Co Ltd
91% Upside

Revenue
Forecast

Revenue Estimate
AFC-HD AMS Life Science Co Ltd

For the last 13 years the compound annual growth rate for AFC-HD AMS Life Science Co Ltd's revenue is 6%. The projected CAGR for the next 5 years is -14%.

6%
Past Growth
-14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
AFC-HD AMS Life Science Co Ltd

Operating Income forecast
is not available for
AFC-HD AMS Life Science Co Ltd

Net Income
Forecast

Net Income Estimate
AFC-HD AMS Life Science Co Ltd

For the last 13 years the compound annual growth rate for AFC-HD AMS Life Science Co Ltd's net income is 7%. The projected CAGR for the next 5 years is -16%.

7%
Past Growth
-16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFC-HD AMS Life Science Co Ltd's stock price target?
Not Available

AFC-HD AMS Life Science Co Ltd doesn't have any price targets made by Wall Street professionals.

What is AFC-HD AMS Life Science Co Ltd's Revenue forecast?
Projected CAGR
-14%

For the last 13 years the compound annual growth rate for AFC-HD AMS Life Science Co Ltd's revenue is 6%. The projected CAGR for the next 5 years is -14%.

What is AFC-HD AMS Life Science Co Ltd's Net Income forecast?
Projected CAGR
-16%

For the last 13 years the compound annual growth rate for AFC-HD AMS Life Science Co Ltd's net income is 7%. The projected CAGR for the next 5 years is -16%.

Back to Top